NCT07287670: EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
- State
- Under way
- Phase
- Phase 2
- People
- 85 planned
- Started
- 16 Apr 2026
- Primary completion
- Dec 2028
- Arms
- MTX-474
- Results
- None posted
- 17 Dec 2025: Trial registered
- 16 Apr 2026: Trial started